PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704) Journal Article


Authors: Zhang, T.; Ballman, K. V.; Choudhury, A. D.; Chen, R. C.; Watt, C.; Wen, Y.; Zemla, T.; Emamekhoo, H.; Gupta, S.; Morris, M. J.; George, D. J.; Choueiri, T. K.
Article Title: PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-01
Language: English
ACCESSION: WOS:000487345803363
DOI: 10.1200/JCO.2019.37.15_suppl.TPS4596
PROVIDER: wos
Notes: Meeting Abstract -- Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL -- S -- Source: Wos
Altmetric Score